ADA 2026

The Hypoglycemia Prevention Program (HPP) for Primary Care: Pilot Clinical Trial

by Prateek Chopra | June 22, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Clinical Need Program Overview Intervention Components Patient Participation Key Findings Clinical Implications The EHR-integrated HPP was well accepted by patients and improved hypoglycemia prevention practices in primary care. Further studies are warranted to determine its long-term impact on reducing hypoglycemic events.

The Hypoglycemia Prevention Program (HPP) for Primary Care: Pilot Clinical Trial Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Putting It All Together: Strategies for Implementation

by Prateek Chopra | June 22, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Person-Centered Care Framework: Foundations of E ective Implementation: Lifestyle Interventions: Weight Management Strategies: Role of Technology: Health-System Transformation: Equity and Access Considerations: Remaining Knowledge Gaps: Successful implementation of contemporary T2D care requires a personalized, multidisciplinary approach that combines lifestyle modification, evidence-based therapies, digital health technologies, and

Putting It All Together: Strategies for Implementation Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Personalized Approach to Treatment Based on IndividualCharacteristics and Associated Long-Term Conditions

by Prateek Chopra | June 21, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Evolving Treatment Approach: Management of Atherosclerotic Cardiovascular Disease (ASCVD): Management of Heart Failure and Chronic Kidney Disease: Obesity-Focused Treatment Strategies: Factors Influencing Treatment Selection: Principles of Personalized Care: Personalized diabetes care enables treatment decisions to be aligned with each individual’s cardiovascular, renal, metabolic, and obesity-related risk

Personalized Approach to Treatment Based on IndividualCharacteristics and Associated Long-Term Conditions Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Interventions and Approaches to Type 2Diabetes Treatment

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Treatment Paradigm Shift: Role of SGLT2 Inhibitors: Role of GLP-1 Receptor Agonists: Established Glucose-Lowering Therapies: Metformin: Sulfonylureas: Insulin: Principles of Individualized Care: Contemporary T2DM management extends beyond glycemic control to address cardiovascular, renal, and metabolic health. Individualized treatment strategies

Interventions and Approaches to Type 2Diabetes Treatment Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Insulin Resistance: A Cause or Consequence of Metabolic Dysfunction? A Genetic Perspective with Evidence for the Existence of Both

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Research Objective: Sources of Evidence: Evidence for Primary Insulin Resistance: Evidence for Secondary Insulin Resistance: Insights from Polygenic Analyses: Implications for Diabetes Risk Stratification: Human genetic evidence indicates that insulin resistance arises through multiple biological pathways rather than a

Insulin Resistance: A Cause or Consequence of Metabolic Dysfunction? A Genetic Perspective with Evidence for the Existence of Both Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Cost-Effectiveness of Age-Specific Remote Education to Initiate and Sustain Use of CGM in Older Adults with Diabetes on Insulin

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Modeling Approach: Intervention: Projected Clinical Outcomes: Benefits in Type 1 Diabetes: Benefits in Type 2 Diabetes: Quality of Life and Economic Outcomes: Clinical Implications: Long-term projections based on the REST intervention demonstrated meaningful reductions in diabetes- and cardiovascular-related complications,

Cost-Effectiveness of Age-Specific Remote Education to Initiate and Sustain Use of CGM in Older Adults with Diabetes on Insulin Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Effects of Ketogenic and Low-Carbohydrate Diet on Glucose and Weight Control in T2DM Patients Along with Metabolome Change

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Study Design: Methods: Effects on Glycemic Control and Body Weight: Metabolomic Findings: In the KD group: Clinical Implications: The ketogenic diet produced the greatest improvements in glycemic control and weight reduction among obese individuals with T2DM, while both ketogenic

Effects of Ketogenic and Low-Carbohydrate Diet on Glucose and Weight Control in T2DM Patients Along with Metabolome Change Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Imaging: Incorporating Imaging Findings into Risk Assessment andPrevention Strategies

by Prateek Chopra | June 13, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Cardiovascular Risk in Diabetes: Impact of Cardiovascular Disease in Diabetes: Role of Coronary Artery Calcification (CAC): Evidence from Clinical Studies: Guideline Recommendations: Additional Risk Stratification Considerations: Clinical Implications: Imaging findings, particularly coronary artery calcification, provide valuable information for cardiovascular

Imaging: Incorporating Imaging Findings into Risk Assessment andPrevention Strategies Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Biomarkers: Which Ones Are Worthwhile? (Personalised Risk)

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Background: Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in individuals with type 2 diabetes (T2D), despite advances in risk factor management. Accurate risk stratification is essential to identify high-risk individuals and guide personalized preventive strategies.

Biomarkers: Which Ones Are Worthwhile? (Personalised Risk) Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

PCE, PREVENT, SCORE2-Diabetes: Understanding the CVD Risk Prediction Tools in People with Diabetes

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Need for Improved Risk Assessment: PREVENT Risk Equations: Diabetes and CKD-Specific Risk Stratification: SCORE2-Diabetes Model: Validation and Clinical Relevance: PREVENT and SCORE2-Diabetes represent important advances in cardiovascular risk prediction for people with diabetes. By incorporating diabetes-specific factors and broader

PCE, PREVENT, SCORE2-Diabetes: Understanding the CVD Risk Prediction Tools in People with Diabetes Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,
Scroll to Top